These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 35981433)
1. Implantation of two generations of Bonebridge after mastoid obliteration with bioactive glass S53P4. Skarzynski PH; Krol B; Skarzynski H; Cywka KB Am J Otolaryngol; 2022; 43(5):103601. PubMed ID: 35981433 [TBL] [Abstract][Full Text] [Related]
2. Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results. Król B; Cywka KB; Skarżyńska MB; Skarżyński PH Life (Basel); 2021 Apr; 11(5):. PubMed ID: 33921929 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Bonebridge BCI 602 active bone conductive implant in adults: efficacy and stability of audiological, surgical, and functional outcomes. Cywka KB; Skarzynski PH; Krol B; Hatzopoulos S; Skarzynski H Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3525-3534. PubMed ID: 35182185 [TBL] [Abstract][Full Text] [Related]
4. Mastoid obliteration with S53P4 bioactive glass after canal wall down mastoidectomy: Preliminary results. Król B; Cywka KB; Skarżyńska MB; Skarżyński PH Am J Otolaryngol; 2021; 42(2):102895. PubMed ID: 33429176 [TBL] [Abstract][Full Text] [Related]
5. Mastoid Obliteration with S53P4 Bioactive Glass Can Make Bonebridge Implantation Feasible: A Case Report. Król B; Porowski M; Cywka KB; Skarżyńska MB; Skarżyński PH Am J Case Rep; 2020 Nov; 21():e925914. PubMed ID: 33168798 [TBL] [Abstract][Full Text] [Related]
6. The Bonebridge BCI 602 Active Transcutaneous Bone Conduction Implant in Children: Objective and Subjective Benefits. Cywka KB; Skarżyński H; Król B; Skarżyński PH J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945210 [TBL] [Abstract][Full Text] [Related]
7. Tolerance and safety of 45S5 bioactive glass used in obliteration procedures during middle ear surgery: Preliminary results. Al Tamami N; Bawazeer N; Fieux M; Zaouche S; Tringali S Am J Otolaryngol; 2020; 41(6):102542. PubMed ID: 32620365 [TBL] [Abstract][Full Text] [Related]
8. Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients. Vos J; de Vey Mestdagh P; Colnot D; Borggreven P; Orelio C; Quak J Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4121-4126. PubMed ID: 28956143 [TBL] [Abstract][Full Text] [Related]
9. Mastoid Obliteration Using S53P4 Bioactive Glass in Cholesteatoma Surgery: A 10-Year Single-Center Experience in 173 Adult Patients with Long-Term Magnetic Resonance Imaging Controlled Follow-up. Kroon VJ; Mes SW; Borggreven PA; van de Langenberg R; Colnot DR; Quak JJ Otol Neurotol; 2022 Dec; 43(10):1181-1188. PubMed ID: 36099589 [TBL] [Abstract][Full Text] [Related]
10. Audiological effectiveness of Bonebridge implantation for bilateral congenital malformation of the external and middle ear. Ren R; Zhao S; Wang D; Li Y; Ma X; Li Y; Fu X; Chen P; Dou J Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2755-2762. PubMed ID: 31267176 [TBL] [Abstract][Full Text] [Related]
12. A middle ear implant with a titanium canal wall prosthesis for a case of an open mastoid cavity. Deveze A; Rameh C; Sanjuan M; Lavieille JP; Magnan J Auris Nasus Larynx; 2010 Oct; 37(5):631-5. PubMed ID: 20167445 [TBL] [Abstract][Full Text] [Related]
14. Improvement of speech perception in quiet and in noise without decreasing localization abilities with the bone conduction device Bonebridge. Weiss R; Leinung M; Baumann U; Weißgerber T; Rader T; Stöver T Eur Arch Otorhinolaryngol; 2017 May; 274(5):2107-2115. PubMed ID: 28032241 [TBL] [Abstract][Full Text] [Related]
15. Bioglass reconstruction of posterior meatal wall after canal wall down mastoidectomy. Sorour SS; Mohamed NN; Abdel Fattah MM; Elbary MEA; El-Anwar MW Am J Otolaryngol; 2018; 39(3):282-285. PubMed ID: 29526381 [TBL] [Abstract][Full Text] [Related]
16. Hearing and hearing rehabilitation after obliteration of troublesome mastoid cavities. Geerse S; Bost TJM; Allagul S; de Wolf MJF; Ebbens FA; van Spronsen E Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3307-3313. PubMed ID: 32444965 [TBL] [Abstract][Full Text] [Related]
17. Audiological and clinical outcomes of a transcutaneous bone conduction hearing implant: Six-month results from a multicentre study. den Besten CA; Monksfield P; Bosman A; Skarzynski PH; Green K; Runge C; Wigren S; Blechert JI; Flynn MC; Mylanus EAM; Hol MKS Clin Otolaryngol; 2019 Mar; 44(2):144-157. PubMed ID: 30358920 [TBL] [Abstract][Full Text] [Related]
18. The Bonebridge implant in older children and adolescents with mixed or conductive hearing loss: Audiological outcomes. Ratuszniak A; Skarzynski PH; Gos E; Skarzynski H Int J Pediatr Otorhinolaryngol; 2019 Mar; 118():97-102. PubMed ID: 30599287 [TBL] [Abstract][Full Text] [Related]
19. Cholesteatoma surgery in the pediatric population: remaining challenges in the era of mastoid obliteration. Kroon VJ; Mes SW; Borggreven PA; van de Langenberg R; Colnot DR; Quak JJ Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1713-1722. PubMed ID: 36208330 [TBL] [Abstract][Full Text] [Related]
20. [Clinical application of retrosigmoid approach for BONEBRIDGE implantation after auricle reconstruction using expanded postauricular flap]. Wang DN; Wang BQ; Ren R; Chen PW; Liu YJ; Zhang QG; Zhao SQ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Oct; 58(10):980-985. PubMed ID: 37840163 [No Abstract] [Full Text] [Related] [Next] [New Search]